The U.S. government's new directive mandates federal workers to report on diversity initiatives, sparking fears and controversy among employees.
US Federal Employees Face Pressure to Report DEI Activities Under Trump's Orders

US Federal Employees Face Pressure to Report DEI Activities Under Trump's Orders
Authorities threaten consequences for employees who fail to disclose diversity efforts.
The Trump administration has intensified scrutiny on federal employees regarding diversity, equity, and inclusion (DEI) efforts, as thousands were ordered via email to report any measures that may conceal such initiatives. This directive follows President Donald Trump's earlier executive orders which banned DEI offices and programs in the government. The emails, which were distributed on Wednesday, urged employees to share "all facts and circumstances" related to DEI within a truncated timeline of just ten days, invoking a sense of paranoia among personnel.
"We're really freaked out and overwhelmed," remarked a Department of Health and Human Services (HHS) employee, reflecting the sentiment among those receiving the orders. The Office of Personnel Management further mandated agencies to notify their staff by 5 PM Eastern time that day, supplying a template for communication to ensure compliance. Variations of the messages led to confusion; for instance, employees at the Treasury Department received a version that notably omitted threats of "adverse consequences" for non-reporting.
Trump's initial executive orders aimed to dismantle DEI programs—which were created to enhance minority representation and awareness about discrimination—have drawn sharp critiques and support alike. Many supporters of the move argue that DEI frameworks inherently promote discrimination. Advocates like Yukong Mike Zhao from the Asian American Coalition for Education lauded the executive orders as a major advancement in civil rights, portraying them as steps toward a 'color-blind' society.
However, several federal workers, speaking anonymously for fear of retribution, described the communications as heavy-handed intimidation tactics rather than efforts to enhance fairness. An employee from HHS criticized the notion of diversity-driven practices, acknowledging the significance of a varied workforce but opposing punitive measures towards their colleagues.
Reports from within the agencies reveal a significant disruption caused by these measures. Questions regarding future hiring protocols and the continuation of policies aimed at equitable opportunities loom large, sowing confusion about permissible actions under the new regulations. A second HHS employee indicated that all hiring and research grants had been frozen, while the Food and Drug Administration (FDA) reported a pause on all DEI-related activities.
Despite these upheavals, many employees are left in limbo. An FDA staff member mentioned no receipt of the directive but did express unease regarding potential ramifications on their overall work landscape. The current restrictions are raising concerns about their possible extended impact beyond government employment, particularly affecting grants designed to foster opportunities for minority scientists and medical professionals.
As this situation unfolds, the consequences of Trump's aggressive stance against DEI initiatives remain uncertain. Further responses from the White House are awaited as staff members navigate this contentious new landscape.
"We're really freaked out and overwhelmed," remarked a Department of Health and Human Services (HHS) employee, reflecting the sentiment among those receiving the orders. The Office of Personnel Management further mandated agencies to notify their staff by 5 PM Eastern time that day, supplying a template for communication to ensure compliance. Variations of the messages led to confusion; for instance, employees at the Treasury Department received a version that notably omitted threats of "adverse consequences" for non-reporting.
Trump's initial executive orders aimed to dismantle DEI programs—which were created to enhance minority representation and awareness about discrimination—have drawn sharp critiques and support alike. Many supporters of the move argue that DEI frameworks inherently promote discrimination. Advocates like Yukong Mike Zhao from the Asian American Coalition for Education lauded the executive orders as a major advancement in civil rights, portraying them as steps toward a 'color-blind' society.
However, several federal workers, speaking anonymously for fear of retribution, described the communications as heavy-handed intimidation tactics rather than efforts to enhance fairness. An employee from HHS criticized the notion of diversity-driven practices, acknowledging the significance of a varied workforce but opposing punitive measures towards their colleagues.
Reports from within the agencies reveal a significant disruption caused by these measures. Questions regarding future hiring protocols and the continuation of policies aimed at equitable opportunities loom large, sowing confusion about permissible actions under the new regulations. A second HHS employee indicated that all hiring and research grants had been frozen, while the Food and Drug Administration (FDA) reported a pause on all DEI-related activities.
Despite these upheavals, many employees are left in limbo. An FDA staff member mentioned no receipt of the directive but did express unease regarding potential ramifications on their overall work landscape. The current restrictions are raising concerns about their possible extended impact beyond government employment, particularly affecting grants designed to foster opportunities for minority scientists and medical professionals.
As this situation unfolds, the consequences of Trump's aggressive stance against DEI initiatives remain uncertain. Further responses from the White House are awaited as staff members navigate this contentious new landscape.